Delivery Order SPE2DR25D1205-SPE2DR26F0XC7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) vaccine syringes in the amount of $1,302.58. The order was competitively awarded without a set-aside designation and is scheduled for completion by November 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $2,987.50 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was issued on November 18, 2025, with an ultimate completion date of December 10, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,684.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine syringes (12 years and up, 0.5 mL). The award, issued on November 18, 2025, is due for completion by December 10, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance based in Conshohocken, Pennsylvania and an ultimate completion date of December 26, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,718.65 to AmerisourceBergen Drug Corp for the supply of SPIKEVAX 2025-26 (12 years and up) in 0.5ML syringes. The non-competitive delivery order carries a firm fixed price structure with an ultimate completion date of November 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,632.00 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (12 years and up), 0.5 milliliter syringes. The contract is a firm fixed-price delivery order with no set-aside designation, awarded on December 11, 2025, with an ultimate completion date of January 5, 2026. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- The Defense Logistics Agency awarded a $1,052.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, with an ultimate completion date of January 2, 2026. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccines (12 years and up) in 0.5ml syringes, with a completion date of January 2, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0XC7Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,632.00 delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine syringes (12 years and up) on November 24, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a comprehensive range of medical products to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contracts demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, from specialty medications and vaccines to medical devices and supplies. This delivery order for Spikevax vaccine reflects the ongoing federal demand for immunization products to support military personnel and beneficiary populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 11/23/25 |